KYMR
Price
$43.24
Change
-$0.00 (-0.00%)
Updated
Oct 10 closing price
27 days until earnings call
NTLA
Price
$17.79
Change
-$0.00 (-0.00%)
Updated
Oct 10 closing price
20 days until earnings call
Ad is loading...

KYMR vs NTLA

Header iconKYMR vs NTLA Comparison
Open Charts KYMR vs NTLABanner chart's image
Kymera Therapeutics
Price$43.24
Change-$0.00 (-0.00%)
Volume$255.19K
CapitalizationN/A
Intellia Therapeutics
Price$17.79
Change-$0.00 (-0.00%)
Volume$1.84M
CapitalizationN/A
View a ticker or compare two or three
KYMR vs NTLA Comparison Chart
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
KYMR vs. NTLA commentary
Oct 12, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and NTLA is a Hold.

COMPARISON
Comparison
Oct 12, 2024
Stock price -- (KYMR: $43.24 vs. NTLA: $17.79)
Brand notoriety: KYMR and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 61% vs. NTLA: 131%
Market capitalization -- KYMR: $3.14B vs. NTLA: $2.13B
KYMR [@Biotechnology] is valued at $3.14B. NTLA’s [@Biotechnology] market capitalization is $2.13B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 0 green, 5 red.
According to our system of comparison, both KYMR and NTLA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 5 TA indicator(s) are bullish while NTLA’s TA Score has 4 bullish TA indicator(s).

  • KYMR’s TA Score: 5 bullish, 5 bearish.
  • NTLA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both KYMR and NTLA are a good buy in the short-term.

Price Growth

KYMR (@Biotechnology) experienced а -0.39% price change this week, while NTLA (@Biotechnology) price change was +0.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

KYMR is expected to report earnings on Feb 20, 2025.

NTLA is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($3.15B) has a higher market cap than NTLA($2.13B). KYMR YTD gains are higher at: 69.835 vs. NTLA (-41.653). KYMR has higher annual earnings (EBITDA): -152.44M vs. NTLA (-514.18M). NTLA has more cash in the bank: 691M vs. KYMR (510M). KYMR has less debt than NTLA: KYMR (88.2M) vs NTLA (106M). KYMR has higher revenues than NTLA: KYMR (88.6M) vs NTLA (46M).
KYMRNTLAKYMR / NTLA
Capitalization3.15B2.13B147%
EBITDA-152.44M-514.18M30%
Gain YTD69.835-41.653-168%
P/E RatioN/AN/A-
Revenue88.6M46M193%
Total Cash510M691M74%
Total Debt88.2M106M83%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
96
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYMRNTLA
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 29 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME20.910.41
+2.00%
GameStop Corp
SPY576.13-1.01
-0.18%
SPDR® S&P 500® ETF Trust
AAPL229.04-0.50
-0.22%
Apple
BTC.X60274.500000-307.601560
-0.51%
Bitcoin cryptocurrency
TSLA238.77-2.28
-0.95%
Tesla

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with RXRX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-0.23%
RXRX - KYMR
51%
Loosely correlated
+0.49%
CRSP - KYMR
51%
Loosely correlated
-0.02%
NTLA - KYMR
49%
Loosely correlated
+0.79%
ACLX - KYMR
49%
Loosely correlated
-0.05%
EDIT - KYMR
48%
Loosely correlated
-5.13%
More

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with EDIT. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
+0.79%
EDIT - NTLA
75%
Closely correlated
-5.13%
BEAM - NTLA
75%
Closely correlated
-1.75%
CRSP - NTLA
71%
Closely correlated
-0.02%
VCYT - NTLA
69%
Closely correlated
+1.10%
PRME - NTLA
67%
Closely correlated
+0.56%
More